Non-injection route: Semax, Selank, and VIP often have intranasal use cases
Trust our team to support your research with the best peptide solutions
The regimen emphasizes stage-specific interventions: early-stage management combines A-clearing agents (e.g., aducanumab) with ferroptosis inhibitors (e.g., sulforaphane via Nrf2/GPX4 activation) to reduce A plaques and counteract oxidative stress/lipid peroxidation
Jablonska E, Gromadzinska J, Peplonska B, Fendler W, Reszka E, Krol MB, Wieczorek E, Bukowska A, Gresner P, Galicki M, et al
Lyoprotectants prevent bilayer damage, leakage of encapsulated materials and vesicle aggregation
The four stages of this response include: Hemostasis (Stopping the Bleed): This happens in the first few minutes